Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.